Lumatix Biotech

Lumatix Biotech is dedicated to advancing antibody manufacturing through innovative biotechnology research. Specializing in the development of a light-controlled affinity matrix, Lumatix Biotech is poised to revolutionize the isolation of antibodies, emphasizing both product quality and economic efficiency. The company’s groundbreaking chromatography technology aims to surpass traditional Protein A chromatography by integrating several proprietary technologies, with the light-controlled binding mode enabling antibody capture in user-defined buffers and eliminating the need for acidic elution.

Located at Lichtenbergstraße 8, Garching bei München, DE, Lumatix Biotech is committed to achieving ambitious goals and setting new standards in the biotech industry. With a focus on continuous innovation, Lumatix Biotech is establishing itself as a leader in biotechnology research, driving advancements that promise to transform antibody manufacturing processes.

Lumatix Biotech invites you to explore the potential of its cutting-edge solutions and discover how its technologies can enhance your processes. For more information, please visit the website. Manager, we invite you to create a customized and exclusive company showcase and product listing on our platform.